Magnet Biomedicine Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Novel Molecular Glue Medicines

Posted on by

Collaboration combines Magnet Biomedicine’s rational approach to molecular glues and TrueGlue™ discovery platform with Lilly’s deep expertise in developing small molecule therapeutics Company to receive up to $40 million in upfront, near-term payments, and an equity investment, and…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.